FDA Inspection 1053823 — Merck Serono SA (Vevey)
The FDA completed an inspection of Merck Serono SA (Vevey) on April 30, 2018 in Corsier-Sur-Vevey. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 30, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Corsier-Sur-Vevey (Switzerland)